[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AR102214A1 - Un dispositivo para la administración transdermal de buprenorfina - Google Patents

Un dispositivo para la administración transdermal de buprenorfina

Info

Publication number
AR102214A1
AR102214A1 ARP150103253A ARP150103253A AR102214A1 AR 102214 A1 AR102214 A1 AR 102214A1 AR P150103253 A ARP150103253 A AR P150103253A AR P150103253 A ARP150103253 A AR P150103253A AR 102214 A1 AR102214 A1 AR 102214A1
Authority
AR
Argentina
Prior art keywords
transdermal administration
buprenorfina
buprenorphine
adhesive matrix
sheet
Prior art date
Application number
ARP150103253A
Other languages
English (en)
Original Assignee
Amarin Tech S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amarin Tech S A filed Critical Amarin Tech S A
Priority to ARP150103253A priority Critical patent/AR102214A1/es
Priority to MX2018004246A priority patent/MX2018004246A/es
Priority to CA3000891A priority patent/CA3000891A1/en
Priority to PCT/EP2016/074072 priority patent/WO2017060472A1/en
Priority to US15/766,124 priority patent/US20190117585A1/en
Priority to EP16778062.6A priority patent/EP3359143A1/en
Publication of AR102214A1 publication Critical patent/AR102214A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un dispositivo para la administración transdermal de buprenorfina que comprende una matriz adhesiva, una lámina de soporte y una lámina de despegue, en donde dicha matriz adhesiva comprende un polímero acrílico adhesivo no entrecruzado y sin funcionalidad carboxílica, buprenorfina base, ácido levulínico y miristato de isopropilo.
ARP150103253A 2015-10-08 2015-10-08 Un dispositivo para la administración transdermal de buprenorfina AR102214A1 (es)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ARP150103253A AR102214A1 (es) 2015-10-08 2015-10-08 Un dispositivo para la administración transdermal de buprenorfina
MX2018004246A MX2018004246A (es) 2015-10-08 2016-10-07 Dispositivo para administracion transdermal de buprenorfina.
CA3000891A CA3000891A1 (en) 2015-10-08 2016-10-07 A device for the transdermal delivery of buprenorphine
PCT/EP2016/074072 WO2017060472A1 (en) 2015-10-08 2016-10-07 A device for the transdermal delivery of buprenorphine
US15/766,124 US20190117585A1 (en) 2015-10-08 2016-10-07 A device for the transdermal delivery of buprenorphine
EP16778062.6A EP3359143A1 (en) 2015-10-08 2016-10-07 A device for the transdermal delivery of buprenorphine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP150103253A AR102214A1 (es) 2015-10-08 2015-10-08 Un dispositivo para la administración transdermal de buprenorfina

Publications (1)

Publication Number Publication Date
AR102214A1 true AR102214A1 (es) 2017-02-15

Family

ID=58487101

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150103253A AR102214A1 (es) 2015-10-08 2015-10-08 Un dispositivo para la administración transdermal de buprenorfina

Country Status (6)

Country Link
US (1) US20190117585A1 (es)
EP (1) EP3359143A1 (es)
AR (1) AR102214A1 (es)
CA (1) CA3000891A1 (es)
MX (1) MX2018004246A (es)
WO (1) WO2017060472A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022039195A1 (ja) * 2020-08-19 2022-02-24 東洋インキＳｃホールディングス株式会社 貼付剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4446600A1 (de) 1994-12-24 1996-06-27 Lohmann Therapie Syst Lts Transdermale Resorption von Wirkstoffen aus unterkühlten Schmelzen
DE102006054731B4 (de) * 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
BR112013012156A2 (pt) * 2010-11-17 2017-12-05 Hexal Ag sistema terapêutico transdérmico e método de produção de um sistema terapêutico transdérmico
WO2014078576A2 (en) * 2012-11-14 2014-05-22 Abon Pharmaceuticals, Llc Oral transmucosal drug delivery system
BR112015029920A2 (pt) * 2013-06-04 2017-07-25 Lts Lohmann Therapie Systeme Ag sistema de administração transdérmica

Also Published As

Publication number Publication date
EP3359143A1 (en) 2018-08-15
WO2017060472A1 (en) 2017-04-13
CA3000891A1 (en) 2017-04-13
MX2018004246A (es) 2018-06-27
US20190117585A1 (en) 2019-04-25

Similar Documents

Publication Publication Date Title
CL2016002381A1 (es) Sistema y método para activar y desactivar múltiples celdas secundarias
CR20150647A (es) Sistema de liberación transdérmica
WO2016036447A3 (en) Semantic framework for variable haptic output
AR108830A1 (es) Sistema de control de acceso de área y método
BR112016027192A2 (pt) método de apresentar uma mensagem de áudio para um usuário de um dispositivo móvel, método de configurar um servidor e dispositivo móvel
CL2016000042A1 (es) Uso de una combinación de un inhibidor de mek y un inhibidor de erk para el tratamiento de enfermedades hiperproliferativas.
BR112018068843A2 (pt) método de comunicação entre dispositivos, e dispositivo entre dispositivos
EP3343252A4 (en) DIFFUSION PLATE, DISPLAY DEVICE, PROJECTION DEVICE, AND LIGHTING DEVICE
AR088973A1 (es) Aparato de procesamiento de informacion, metodo de procesamiento de informacion, y programa
EP3125210A4 (en) Driving support information generation system, driving support information provision device, driving support information generation method, and driving support information generation program
AR105072A1 (es) Sistemas de adhesivos de laminación de poliéster-policarbonato-poliol
DK3201260T3 (da) Vandig koagulerbar polymerdispersion og anvendelse af denne som klæbemiddel
AR095258A1 (es) Composiciones transdérmicas de metilfenidato con adhesivos a base de goma
DK3316775T3 (da) Engangsklæbemiddelunderlag, som er tilpasset til at blive anbragt på en medicinsk anordning
UY35636A (es) Formulación líquida estable
CL2015002180A1 (es) Terapia de combinación para el tratamiento de neumonía nosocomial
CL2015003109A1 (es) Sistema de control de terminales
BR112013008435A2 (pt) método para obter um serviço, e aparelho para obter um serviço
PH12016501469B1 (en) Ketoprofen-containing poultice
BR112017001764A2 (pt) método, e, aparelho
EP3120993A4 (en) Method for affixing adhesive sheet, and device for affixing adhesive sheet
MX2020003667A (es) Sistema terapeutico transdermico para la administracion transdermica de guanfacina que comprende un polimero de silicona.
BR112018006056A2 (pt) suporte dinâmico para dispositivo oftálmico.
MX2020003665A (es) Sistema terapeutico transdermico para la administracion transdermica de guanfacina que comprende por lo menos un aditivo.
MX2020003662A (es) Sistema terapeutico transdermico para la administracion transdermica de guanfacina que comprende un polimero hibrido acrilico de silicona.

Legal Events

Date Code Title Description
FB Suspension of granting procedure